載入...
Nanomedicines in the treatment of acromegaly: focus on pegvisomant
This article examines the role of pegvisomant in the treatment of acromegaly. This syndrome, caused by excessive growth hormone (GH) secretion by a pituitary adenoma, is associated with a doubled mortality rate and poor quality of life. Pituitary microsurgery has long been the first choice of treatm...
Na minha lista:
Main Authors: | , , , |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
Dove Medical Press
2006
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2676637/ https://ncbi.nlm.nih.gov/pubmed/17722273 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|